Literature DB >> 27650143

Periodic fevers and autoinflammatory syndromes in childhood.

Genevieve T Ostring1,2, Davinder Singh-Grewal3,4,5.   

Abstract

Recurrent fever is a common presentation in paediatric practice and can be caused by a wide variety of diseases including autoinflammatory conditions. The innate immune system plays an essential role in the 'first line' response to infection through mediation of inflammatory responses. Inflammasomes are part of the regulatory process for this system and result in the production of the powerful pro-inflammatory cytokine interleukin-1B. Dysregulation of inflammasomes, and Interleukin 1 production, contributes to the pathogenesis of autoinflammatory diseases. This review focuses on described periodic fever syndromes (PFS) which are now collectively referred to as autoinflammatory syndromes. Conditions discussed include periodic fever aphthous stomatitis pharyngitis and cervical adenopathy, familial Mediterranean fever, tumour necrosis factor receptor-associated periodic syndromes, hyperimmunoglobulinaemia D and the cryopyrin-associated periodic syndromes. Presenting features, complications, diagnostic and treatment approaches for these conditions are discussed. Nonetheless, as most of these conditions are rare and may have significant long-term complications, it is recommended that they be managed in consultations with a physician experienced in managing PFS.
© 2016 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  general paediatrics; rheumatology

Mesh:

Year:  2016        PMID: 27650143     DOI: 10.1111/jpc.13326

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

Review 1.  [Chronic urticaria in childhood : Rational diagnostics and treatment].

Authors:  H Ott
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

2.  The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation.

Authors:  Hang Fu; Mohamad Alabdullah; Julia Großmann; Florian Spieler; Reem Abdosh; Veronika Lutz; Katrin Kalies; Kai Knöpp; Max Rieckmann; Susanne Koch; Michel Noutsias; Claudia Pilowski; Jochen Dutzmann; Daniel Sedding; Stefan Hüttelmaier; Kazuo Umezawa; Karl Werdan; Harald Loppnow
Journal:  Cell Death Dis       Date:  2019-11-21       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.